<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dermira, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dermira, Inc.

    Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering important new treatments to the millions of patients living with chronic skin conditions. We are committed to understanding the needs of both patients and physicians and using our insight to identify and develop leading-edge medical dermatology clinical programs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Thomas G. Wiggans
    • FOUNDED
      2010
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Exicure, Inc.

    Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...

    Exicure, Inc. is a clinical stage biotechnology...

    Filing Type:    PU
    Sorrento Therapeutics, Inc.

    Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stag...

    Sorrento’s lead programs with short-term mile...

    Filing Type:    PU
    Shionogi & Co. Ltd.

    Shionogi & Co. Ltd.

    Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, an...

    Shionogi & Co., Ltd. engages in the research, d...

    Filing Type:    PU
    Opko Health, Inc.

    Opko Health, Inc.

    OPKO Health, Inc. is a diversified healthcare company that seeks to serve unmet pa...

    OPKO Health, Inc. is a diversified healthcare c...

    Filing Type:    PU
    Neurocarrus Inc

    Neurocarrus Inc

    Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...

    Neurocarrus is developing a breakthrough therap...

    Amount Raised:    $344,168.00
    Fundraising Status:    EC
    Filing Type:    CF
    Orchard Therapeutics plc

    Orchard Therapeutics plc

    Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical comp...

    Orchard Therapeutics is a fully integrated comm...

    Filing Type:    PU
    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals is a specialty pharmaceutical company, committed to address...

    Foamix Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Edesa Biotech, Inc.

    Edesa Biotech, Inc.

    Edesa Biotech Inc. is a clinical-stage biopharmaceutical company founded by expert...

    Edesa Biotech Inc. is a clinical-stage biopharm...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.